Ads
related to: pfizer
Search results
Takeda and Pfizer report positive Phase III HD21 trial of ADCETRIS
Clinical Trials Arena via Yahoo Finance· 5 days agoTakeda and Pfizer have announced a positive Phase III HD21 trial, evaluating ADCETRIS (brentuximab...
Relay in clinical trial collaboration with Pfizer for breast cancer combo treatment
Seeking Alpha· 2 days agoRelay Therapeutics collaborates with Pfizer to investigate combination therapy for breast cancer using RLY-2608 and atirmociclib. Read more here.
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Morningstar· 4 days agoPfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman ...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 2 hours agoTwo other companies – Pfizer and Moderna – also manufacture RSV vaccines approved for adults 60 and...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 2 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation...
KION 46 Salinas· 3 hours agoThe JN.1 version of the virus, along with its descendants KP.2 and KP.3 are the most common strain...
Pfizer Is Getting Healthier and There's a Key Level for Buyers to Watch
TheStreet.com· 3 days agoIn the updated daily bar chart of PFE, below, I can see this is the second test of the 200-day...
US FDA expands GSK’s RSV vaccine approval to adults aged 50 to 59
WSAU Wausau· 3 hours agoBy Sriparna Roy and Christy Santhosh (Reuters) -The U.S. Food and Drug Administration approved the...
Paxlovid Doesn't Cure Long COVID
Time via Yahoo News· 7 hours agoPfizer's drug Paxlovid on display in Pembroke Pines, Fla., on July 7, 2022. Credit - Joe Raedle—Getty Images Taking the COVID-19 antiviral Paxlovid does...
A New COVID Booster Targeting JN.1 May Arrive This Fall
Verywell Health via Yahoo News· 8 hours agoAn FDA panel voted to recommend an updated COVID-19 vaccine targeting the JN.1 variant. Here's what...